Mumbai, India

Vijaykumar Bhagwan Deore

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 10(Granted Patents)


Location History:

  • Maharashtra, IN (2014)
  • Mumbai, IN (2012 - 2019)

Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Vijaykumar Bhagwan Deore: An Innovator in Pharmaceutical Research**

Introduction

Vijaykumar Bhagwan Deore, a prominent inventor based in Mumbai, India, has made significant contributions to the field of pharmaceutical research. With a total of four patents to his name, his work primarily focuses on the development of GPR120 agonists, which play a crucial role in treating metabolic disorders.

Latest Patents

Vijaykumar's latest innovations include two notable patents. The first is titled "Substituted phenyl alkanoic acid compounds as GPR120 agonists and uses thereof." This invention describes various compounds, including Formula (I) and its derivatives, which function as GPR120 agonists. These compounds are essential in formulating pharmaceutical compositions aimed at treating diseases or disorders mediated by GPR120.

His second patent, "Compounds for use as GPR120 agonists," also revolves around similar compounds that serve as GPR120 agonists. This innovation focuses on treating metabolic disorders, particularly Type 2 diabetes, highlighting the significant impact of his research on public health.

Career Highlights

Vijaykumar Bhagwan Deore is currently associated with Piramal Enterprises Limited, where he continues to advance his research in pharmaceutical sciences. His work is poised at the intersection of innovative drug development and the ever-evolving demands of healthcare.

Collaborations

In his journey as an inventor, Vijaykumar has collaborated with notable colleagues, such as Sanjay Kumar and Rajiv Sharma. Their combined expertise and teamwork have undoubtedly played a critical role in achieving groundbreaking advancements in their shared research initiatives.

Conclusion

Vijaykumar Bhagwan Deore exemplifies the spirit of innovation within the pharmaceutical sector. His focus on GPR120 agonists highlights a commitment to addressing significant health issues. With a solid portfolio of patents and a collaborative approach in his career, he continues to contribute meaningfully to science and healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…